Total Payments
$2,939
2024 Payments
$282.02
Companies
31
Transactions
155
Medicare Patients
31,329
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$2,857 (97.2%)
Education$82.67 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,857 | 145 | 97.2% |
| Education | $82.67 | 10 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $428.62 | 20 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $356.14 | 18 | $0 (2019) |
| Amgen Inc. | $334.45 | 13 | $0 (2022) |
| Relypsa, Inc. | $329.22 | 20 | $0 (2020) |
| Travere Therapeutics, Inc. | $210.25 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $178.87 | 10 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $130.78 | 6 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $116.07 | 8 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $98.80 | 4 | $0 (2023) |
| Genentech USA, Inc. | $82.80 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $282.02 | 17 | Travere Therapeutics, Inc. ($89.17) |
| 2023 | $205.00 | 9 | Travere Therapeutics, Inc. ($121.08) |
| 2022 | $407.48 | 19 | Aurinia Pharma U.S., Inc. ($99.55) |
| 2021 | $118.14 | 6 | AstraZeneca Pharmaceuticals LP ($35.93) |
| 2020 | $95.14 | 6 | Relypsa, Inc. ($52.90) |
| 2019 | $633.82 | 35 | Otsuka America Pharmaceutical, Inc. ($181.31) |
| 2018 | $512.13 | 28 | Otsuka America Pharmaceutical, Inc. ($162.88) |
| 2017 | $685.68 | 35 | Amgen Inc. ($210.69) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardio-renal | ||||||
| 10/26/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.06 | General |
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.73 | General |
| 09/18/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 08/29/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.78 | General |
| 08/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 08/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: NEPHROLOGY | ||||||
| 07/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Cardio-renal | ||||||
| 06/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: NEPHROLOGY | ||||||
| 05/28/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/22/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Genetic Disease | ||||||
| 02/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEPHROLOGY | ||||||
| 01/24/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.18 | General |
| 11/10/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 11/09/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $97.08 | General |
| 10/23/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/15/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Hematology | ||||||
| 05/01/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: KRYSTEXXA | ||||||
| 04/11/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.84 | General |
| 02/01/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 7,078 | 11,513 | $2.4M | $333,902 |
| 2022 | 49 | 8,828 | 18,486 | $1.3M | $350,519 |
| 2021 | 45 | 7,462 | 16,314 | $1.2M | $318,749 |
| 2020 | 43 | 7,961 | 23,642 | $1.3M | $340,705 |
Total Patients
31,329
Total Services
69,955
Medicare Billing
$1.3M
Procedure Codes
180
All Medicare Procedures & Services
180 procedure records from CMS Medicare Utilization — Page 5 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 98 | 204 | $42,822 | $11,430 | 26.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 449 | 715 | $25,182 | $7,513 | 29.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 20 | 33 | $22,614 | $7,505 | 33.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 579 | 867 | $27,545 | $6,693 | 24.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 67 | 140 | $23,100 | $6,312 | 27.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $25,822 | $6,308 | 24.4% |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | Office | 2021 | 114 | 149 | $18,832 | $6,266 | 33.3% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2021 | 92 | 167 | $25,050 | $6,245 | 24.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 562 | 834 | $17,639 | $4,284 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 60 | $12,341 | $3,872 | 31.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 206 | 206 | $10,494 | $3,636 | 34.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 30 | 32 | $11,640 | $3,217 | 27.6% |
| 84100 | Phosphate level | Office | 2021 | 434 | 676 | $12,087 | $3,187 | 26.4% |
| 84156 | Total protein level, urine | Office | 2021 | 583 | 873 | $13,095 | $3,178 | 24.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 18 | $7,379 | $2,505 | 34.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 540 | 800 | $7,200 | $2,382 | 33.1% |
| 84550 | Uric acid level, blood | Office | 2021 | 330 | 470 | $8,686 | $2,117 | 24.4% |
| 80069 | Kidney function blood test panel | Office | 2021 | 218 | 232 | $6,542 | $1,985 | 30.3% |
| G0420 | Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour | Office | 2021 | 18 | 19 | $5,986 | $1,489 | 24.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 18 | 24 | $4,534 | $1,287 | 28.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 32 | $6,784 | $1,166 | 17.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 370 | 508 | $4,663 | $1,133 | 24.3% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 72 | 83 | $4,624 | $1,107 | 23.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 259 | 350 | $8,736 | $1,101 | 12.6% |
| 83550 | Iron binding capacity | Office | 2021 | 73 | 84 | $3,001 | $718.86 | 24.0% |
About Dr. John Mccarley, M.D
Dr. John Mccarley, M.D is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760480321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mccarley, M.D has received a total of $2,939 in payments from pharmaceutical and medical device companies, with $282.02 received in 2024. These payments were reported across 155 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,857).
As a Medicare-enrolled provider, Mccarley has provided services to 31,329 Medicare beneficiaries, totaling 69,955 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 180 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Chattanooga, TN
- Active Since 07/08/2005
- Last Updated 05/28/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1760480321
Products in Payments
- ACTHAR (Biological) $436.36
- Veltassa (Drug) $383.93
- JYNARQUE (Drug) $261.54
- Parsabiv (Biological) $258.10
- SAMSCA (Drug) $167.08
- LUPKYNIS (Drug) $130.78
- LOKELMA (Drug) $111.96
- Rayaldee (Drug) $100.89
- Rituxan (Biological) $82.80
- Kerendia (Drug) $70.39
- ULTOMIRIS (Biological) $67.68
- INJECTAFER (Drug) $47.32
- Parsabiv (Drug) $38.68
- Sensipar (Drug) $37.67
- PURIFIED CORTROPHIN GEL (Drug) $37.53
- BENLYSTA (Biological) $36.00
- INVOKANA (Drug) $31.95
- FARXIGA (Drug) $30.54
- NATPARA (Drug) $28.96
- KRYSTEXXA (Biological) $28.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Nephrology $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Nephrology $2,929
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449
Claude Galphin, Md, MD
Nephrology — Payments: $2,379
Nephrology $2,379